1. 3,7-Dihydroxytropolones Inhibit Initiation of Hepatitis B Virus Minus-strand DNA Synthesis. Bak, E., J.T. Miller, A. Noronha, J. Tavis, E. Gallicchio, R.P. Murelli, and S.F.J. Le Grice. Molecules, 2020. 25(19): 4434. PMID[32992516]. PMCID[PMC7583054].
[PubMed]. HBV_12_2020.
2. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture. Hamada-Tsutsumi, S., M. Onishi, K. Matsuura, M. Isogawa, K. Kawashima, Y. Sato, and Y. Tanaka. International Journal of Molecular Sciences, 2020. 21(19): 7251. PMID[33019495]. PMCID[PMC7583928].
[PubMed]. HBV_12_2020.
3. Selective Hepatitis B and D Virus Entry Inhibitors from the Group of Pentacyclic Lupane-type Betulin-derived Triterpenoids. Kirstgen, M., K. Lowjaga, S.F. Müller, N. Goldmann, F. Lehmann, S. Alakurtti, J. Yli-Kauhaluoma, D. Glebe, and J. Geyer. Scientific Reports, 2020. 10(1): 21772. PMID[33303817]. PMCID[PMC7729925].
[PubMed]. HBV_12_2020.
4. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Lee, H.W., J.Y. Park, T. Hong, M.S. Park, and S.H. Ahn. Clinical Gastroenterology and Hepatology, 2020. 18(13): p. 3043-3045. PMID[31589980].
[PubMed]. HBV_12_2020.
5. The Dihydroquinolizinone Compound RG7834 Inhibits the Polyadenylase Function of PAPD5 and PAPD7 and Accelerates the Degradation of Matured Hepatitis B Virus Surface Protein mRNA. Sun, L., F. Zhang, F. Guo, F. Liu, J. Kulsuptrakul, A. Puschnik, M. Gao, R. Rijnbrand, M. Sofia, T. Block, and T. Zhou. Antimicrobial Agents & Chemotherapy, 2020. 65(1): e00640-00620. PMID[33046485].
[PubMed]. HBV_12_2020.
6. Synthesis of Celastrol Derivatives as Potential Non-nucleoside Hepatitis B Virus Inhibitors. Zhang, H. and G. Lu. Chemical Biology & Drug Design, 2020. 96(6): p. 1380-1386. PMID[32573976].
[PubMed]. HBV_12_2020.
Patent Citations
7. Fused Heterocyclic Derivatives as Antiviral Agents and Their Preparation. Deratt, L.G., C.-Y. Wang, J.M. Berke, and S.D. Kuduk. Patent. 2020. 2020-US34654 2020243142: 293pp.
[Patent]. HBV_12_2020.
8. Fused Heterocyclic Derivatives as Antiviral Agents and Their Preparation. Grosse, S.C., L.G. Deratt, K. Vandyck, P.J.-M.B. Raboisson, S.M.A. Pieters, B.R.R. Kesteleyn, W.G. Verschueren, J.M. Berke, M.C.R. LeComte, C. Martinez Lamenca, T.H.M. Jonckers, G. Deng, Y. Jiang, Y. Xu, Z. Cheng, L. Hu, and S.D. Kuduk. Patent. 2020. 2020-US34643 2020243135: 293pp.
[Patent]. HBV_12_2020.
9. Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Hepatitis B and Their Preparation. Huck, J., O. Mammoliti, A.M.E. Palisse, S. Richard, and P.P.A. Savy. Patent. 2020. 2020-EP64364 2020239656: 261pp.
[Patent]. HBV_12_2020.
10. Fused Heterocycle Derivatives as Capsid Assembly Modulators and Their Preparation. Kuduk, S.D. Patent. 2020. 2020-EP64751 2020239864: 117pp.
[Patent]. HBV_12_2020.
11. Diazepinone Derivatives as Capsid Assembly Modulators and Their Preparation. Kuduk, S.D. Patent. 2020. 2020-EP64750 2020239863: 88pp.
[Patent]. HBV_12_2020.
12. Azepines as HBV Capsid Assembly Modulators and Their Preparation. Kuduk, S.D. Patent. 2020. 2020-EP64746 2020239861: 57pp.
[Patent]. HBV_12_2020.
13. Di-Fluoro azepanes as HBV Capsid Assembly Modulators and Their Preparation. Kuduk, S.D. and L.G. Deratt. Patent. 2020. 2020-EP64747 2020239862: 238pp.
[Patent]. HBV_12_2020.
14. Fused Heterocyclic Derivatives as Antiviral Agents and Their Preparation. Kuduk, S.D., S.C. Grosse, S.J. Last, L.G. Deratt, K. Vandyck, P.J.-M.B. Raboisson, J.M. Berke, W.G. Verschueren, M. Obringer, and C.C.C. Doebelin. Patent. 2020. 2020-US34667 2020243153: 245pp.
[Patent]. HBV_12_2020.
15. Hepatitis B Antiviral Agents. Qiu, Y.-L., X. Gao, X. Peng, W. Li, J. Kass, H. Cao, B.-C. Suh, J. Zhang, and Y.S. Or. Patent. 2020. 2020-16891401 20200377519: 35pp.
[Patent]. HBV_12_2020.
16. Hepatitis B Antiviral Agents. Qiu, Y.-L., X. Peng, X. Gao, W. Li, H. Cao, B.-C. Suh, J. Kass, J. Zhang, and Y.S. Or. Patent. 2020. 2020-US36021 2020247561: 83pp.
[Patent]. HBV_12_2020.
17. Pyrrolopyrimidine Derivatives as Hepatitis B Antiviral Agents and Their Preparation. Qiu, Y.-L., X. Peng, W. Li, X. Gao, J. Kass, B.-C. Suh, H. Cao, J. Zhang, and Y.S. Or. Patent. 2020. 2020-US36039 2020247575: 260pp.
[Patent]. HBV_12_2020.
18. Preparation of Tricyclic Compounds Useful for the Treatment of HBV. Vendeville, S. Patent. 2020. 2020-US34746 2020243199: 207pp.
[Patent]. HBV_12_2020.
19. Synthesis of Thiomorpholine Dioxide Compounds for Treating Hepatitis B Viral Infections. Vendeville, S. and P.J.-M.B. Raboisson. Patent. 2020. 2020-US35929 2020247504: 179pp.
[Patent]. HBV_12_2020.